Rise in Unintended Pregnancies to Drive Global Oral Contraceptive Pills Market till 2023

Global Oral Contraceptive Pills Market to be worth US$22.9 bn by 2023, Increasing Awareness Regarding Benefits of Contraceptive Pills Drives Growth Transparency Market Research (TMR) has recently published a study on the global oral contraceptive pills market and estimated the market to rise at a CAGR of 6.60% during the period from 2015 and 2023. The market is expected to increase from a value of US$13.1 bn in 2014 to US$22.9 bn by the end of the forecast period.The research report is titled “Oral Contraceptive Pills Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023.�

The highly competitive oral contraceptive pills market is marked by the presence of several generic product manufacturers, most of which resort to price reduction and free samples to sustain in the market. Oral contraceptive pills are the most common form of reversible contraception in most developed economies of the world, such as Western Europe, the U.S., Canada, and Australia.

The adoption and prescription pattern for oral contraceptive pills varies by region, price, and level of awareness and companies have been taking these factors into consideration to up their share in the market.

The opportunity in the global oral contraceptive pills market was reported to be US$13.1 bn in 2014 and is anticipated to be worth US$22.9 bn by 2023, registering a steady CAGR of 6.6% therein.

Browse Full Research Report on Oral Contraceptive Pills Market: http://www.transparencymarketresearch.com/oralcontraceptive-pills-market.html By type of product, the oral contraceptive pills market has been segmented into progestin-only, combination, and others. The combination oral contraceptive pills segment led the overall market in 2014 and is projected to register the highest growth rate over the course of the forecast period. This growth can be attributed to their higher efficiency in preventing pregnancies, their easy availability, and their rising preference among consumers.

On the basis of category, the market is bifurcated into generic oral contraceptive pills and branded pills. In 2014, generic oral contraceptive pills led the overall market and this segment is projected to record the fastest growth rate by 2023. The growth of this segment can be attributed to the widespread adoption of generic contraceptives facilitated by their low prices and ease of use.

The global contraceptive pills market is geographically segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. North America led the global contraceptive pills market in 2014 primarily owing to a greater incidence of unintended pregnancies in the region. The Centers for Disease Control and Prevention (CDC) states in a study that between 2006 and 2010, a 37% of the total pregnancies in the U.S were unintended.

A significant proportion of these pregnancies led to abortions, which resulted in a massive yet preventable healthcare expenditure. In a bid to curb this avoidable healthcare expense, the governments of North American countries are encouraging women to opt for modern and more effective contraceptive options. The enforcement of the Affordable Care Act, or Obamacare, in the U.S. and various awareness programs by nonprofit organizations have led to the availability of favorable reimbursement policies and the increased sale of emergency oral contraceptive pills in the region.

Asia Pacific is viewed as one of the most attractive market for oral contraceptive pills in the course of the forecast period thanks to the steady economic development in countries such as Singapore, India, China, Australia, and Philippines. This

economic growth has resulted in the increasing disposable income of the people, surging awareness about family planning and contraceptives, and the desire for healthier living. This, in turn, has led to the rising adoption rate of oral contraceptive pills in the region.

The leading players competing in the global oral contraceptive pills market include Bayer AG, Janssen Global Services, LLC, Allergan,plc (Actavis), Teva Pharmaceutical Industries Ltd., Piramal Enterprises Ltd., Pfizer, Inc., Merck & Co., Inc., and Mankind Pharma Ltd. Browse Full Press Release on Oral Contraceptive Pills Market: Press Release

About Us Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com